532965-74-5

Usage

Uses

Used in Pharmaceutical Industry:
4-Ethoxy-2-fluorobenzaldehyde is utilized as an intermediate in the synthesis of various pharmaceuticals, contributing to the development of new medications and therapeutic agents.
Used in Agricultural Industry:
In the agricultural sector, 4-Ethoxy-2-fluorobenzaldehyde serves as an intermediate in the production of agrochemicals, aiding in the creation of effective pest control and crop protection solutions.
Used in Food Industry:
4-Ethoxy-2-fluorobenzaldehyde is employed as a flavoring agent, enhancing the taste profiles of various food products and contributing to the overall sensory experience of consumers.
It is crucial to handle 4-Ethoxy-2-fluorobenzaldehyde with care due to its irritant properties, ensuring that proper safety measures are implemented during its use in these industries.

Upstream product

• 348-27-6 2-fluoro-4-hydroxybenzaldehyde 
• 75-03-6 ethyl iodide 

Downstream Products

• 1282556-89-1 ethyl (4-ethoxy-2-fluorophenyl){[2-(trimethylsilyl)ethoxy]methoxy}acetate 
• 1282556-78-8 ethyl [4-ethoxy2-fluorophenyl](hydroxy)acetate 
• 26018-79-1 6-ethoxybenzo[b]thiophene-2-carboxylic acid 

Relevant academic research and scientific papers

GEMINAL SUBSTITUTED QUINUCLIDINE AMIDE COMPOUNDS AS AGONISTS OF ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTORS

The present invention relates to novel geminal substituted quinuclidine amide compounds, and pharmaceutical compositions of the same, that are suitable as agonists or partial agonists of α7- nAChR, and methods of preparing these compounds and compositions, and the use of these compounds and compositions in methods of maintaining, treating and/or improving cognitive function. In particular, methods of administering the compound or composition to a patient in need thereof, for example a patient with a cognitive deficiency and/or a desire to enhance cognitive function, that may derive a benefit therefrom.

AMINOBENZISOXAZOLE COMPOUNDS AS AGONISTS OF A7-NICOTINIC ACETYLCHOLINE RECEPTORS

The present invention relates to novel aminobenzisoxazole compounds, and pharmaceutical compositions of the same, that are suitable as agonists or partial agonists of ot7-nAChR, and methods of preparing these compounds and compositions, and the use of these compounds and compositions in methods of maintaining, treating and/or improving cognitive function. In particular, methods of administering the compound or composition to a patient in need thereof, for example a patient with a cognitive deficiency and/or a desire to enhance cognitive function, that may derive a benefit therefrom.

PYRROLOPYRIMIDIN-7-ONE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS

Compounds of formula (I) or pharmaceutically acceptable salts thereof wherein R1, R2, R3, R4, and R5 and are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

Compositions containing aromatic aldehydes and their use in treatments

Disclosed are pharmaceutical and cosmetic compositions containing aromatic aldehyde compounds. Some of the disclosed compositions are useful as topical therapeutics for treating inflammatory dermatologic conditions. Some of the compositions are useful in transdermal and other systemic dose forms for treating other inflammatory conditions in mammals.